All In Biotech

Drug Trial Radar · NCT01590446

A Study to Evaluate Safety and Tolerability of BMN 111 Administered to Healthy Adult Volunteers

A Phase 1, Two-Part, Double-Blind, Placebo-Controlled Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Single and Multiple Doses of BMN 111 Administered to Healthy Adult Volunteers

Last checked: Nov 19, 2026Latest source record: Jun 11, 2012 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

74

Planned (sponsor's estimate)

Start

Feb 2012

Primary completion

Jun 2012

Study completion Jun 2012

Sponsor

Lead sponsor
BioMarin PharmaceuticalBioMarin (BMRN)
Sponsor type
Industry
First posted
May 3, 2012

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Randomized
Model
Factorial
Masking
Double (participant, investigator)
Primary purpose
Treatment
Who can join
Male only, from 22 years, up to 45 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

The purpose of this study is to measure how much of the study drug gets into the blood- stream and how long it takes the body to get rid of it when given as a single dose. Information about any side effects that may occur will also be collected.

Conditions

  • Achondroplasia

Interventions

  • BMN 111Drug

    SC injection, Part 1 single dose and Part 2 multiple dose.

  • Normal SalineDrug

    SC injection, Part 1 single dose and Part 2 multiple dose

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Safety based on vitals signsTime frame: Daily throughout the study Assessed for approximately 8 days following each single dose in Part 1, and for approximately 24 days following each daily dose in Part 2
  2. Safety based on adverse eventsTime frame: Daily throughout the study Assessed for approximately 8 days following each single dose in Part 1, and for approximately 24 days following each daily dose in Part 2

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Covance CRU Inc.

    Evansville, Indiana

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.